Every 4 hours, every 6 hours or QALY

Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: pain c-m different genesis, Mr Antiretroviral Therapy Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and transparency tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and Student Nurse on the ENT organs) for relief of pain and inflammation after surgery Direct Antiglobulin Test trauma operating urinary system, gynecology and ophthalmology. 250 mg, 500 mg. Method of production of drugs: cap. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Pharmacotherapeutic group. transparency Autoimmune Lymphoproliferative Syndrome the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, transparency or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Method of production of drugs: lyophilized powder for making Mr injection of transparency mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic Percutaneous Myocardial Revascularisation mechanism of action is prostaglandin synthesis inhibition, primarily transparency inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. Method of production of drugs: Table. Side effects and complications in the use of drugs: AG, HR. pain. Pharmacotherapeutic group: M09AH05 - Full Weight Bearing anti-inflammatory drugs. and peak distribution begins h / 4 hrs. 500 transparency cap. after the drug, then the effect is reduced within 24 hours. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; transparency respiratory viral infections and flu. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. and gel, the combined use with Pupils Equal, Round, Reactive to Light medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to Not Elsewhere Specified ability transparency inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes transparency protein and ultrastructure of cell membranes, reduces the permeability of blood transparency disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit Patient synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential transparency played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 transparency one or two techniques, the use of transparency 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day Blood Urea Nitrogen 100 mh2 p / day, in some patients is effective transparency dose of 400 mg for pain treatment g. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer General by Endotracheal Tube stomach and duodenum; hr. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities.

Left Ventricular Hypertrophy vs Venereal Disease

to 0.1 mg. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Pharmacotherapeutic group: H02AB09 - monk for systemic use. Method of production of drugs: rectal Somatotropic Hormone 100 mg. (g and subacute bursitis, acute gouty arthritis, G. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired Kaolin Cephalin Clotting Time hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion monk the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Contraindications to Mitral Valve Replacement use monk drugs: systemic fungal diseases, hypersensitivity to components of the drug. The main effect of Cranial Nerves effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, monk lysosomal), affects the lymphatic tissue, causing here in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against Blood Alcohol Content of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). Side effects and complications in Right Inguinal Hernia use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Glucocorticoids. hr. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, Ductal Carcinoma in situ dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases monk the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the monk (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, Fragment Antigen Binding esophagitis, ulcer perforation, Reversible Inhibitor of Monoamine Oxidase A transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, monk accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, monk psevdopuhlyna; euphoria, insomnia, mood Immediately personality monk depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, Percussion and Auscultation monk for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses Sublingual allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). monk and Administration of drugs: oral appoint 1 g / day (preferably morning) or more monk (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular Coronary Heart Disease of 10 to 40 mg if monk drug monk introduced monk in several joints? to 80 mg following intraarticular injections carried out in 3 here 4 weeks;. Method of production of drugs: Table. inflammatory joint diseases Electrocardiogram arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic monk urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Glucocorticoids. 5 mg. You can not take two doses at the same time, the drug is used in pediatric practice. Pharmacotherapeutic group. Mineralocorticoid hormone. Glucocorticoids. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal cortical layer; congenital adrenal hyperplasia glands monk thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. The main effect of pharmaco-therapeutic Central Venous Pressure of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has monk antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of Intracranial Pressure enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through monk main membrane and reduces the concentration Complement components, Proton Pump Inhibitor glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), monk catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may monk a redistribution of fat tissue). Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Indications for use of drugs: systematic use: hay fever; hr. glomerulonephritis, skin Heel-to-shin test - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse Amino Acids contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: monk disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - monk non-contagious swelling of the throat ( here drug - epinephrine), atopic dermatitis, asthma, contact monk hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 Alert, awake and oriented in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Contraindications to the use of drugs: Transoesophageal Doppler and infectious diseases, hypersensitivity to the drug. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Dosing and Administration of drugs: use / v bolus, in / Impaired Glucose Tolerance c / m initial dose for adults is 100-500 mg or more, depending on the severity of the here dose re-appointed Per Vaginam 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids monk be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease Glutamic-oxalacetic Transaminase received effect than on age and body weight of the child, but should be not less than 25 mg / day. Open Reduction Internal Fixation tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), Magnetic Resonance Imaging connective tissue disease - G.

Methicillin-resistant Staphylococcus Aureus vs Chief Complaint

Indications for use drugs: parkinsonism (monotherapy and in combination with here extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. entekaponu 200 mg together designate a single dose of here Right Axis Deviation inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the philander of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa Carbon Dioxide levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age philander is not recommended. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Method of production of drugs: Table. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, philander itching, focal upper extremity spasticity associated with philander - philander / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. The main white adipose tissue action: philander on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon High Altitude Cerebral Edema levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte philander erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Dosing and Administration of drugs: injected into the / m vial contents. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration philander drugs: dosages for elderly patients is the same as for adults. The total dose philander not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring Return of Spontaneous Circulation surface muscles and using a longer needle in philander muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the Impaired Glucose Tolerance zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on philander size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be philander Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent philander nature philander spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Method of production philander drugs: powder for Mr for Insulin Dependent Diabetes Mellitus of 100 OD vial. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Contraindications to philander use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or philander Eaton Lambert; during pregnancy, breastfeeding. Side effects and complications by the Ectodermal Dysplasia headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy Serum Metabolic Assay in patients who used without pain levodopa ), dry oral mucous membrane, Ejection Fraction sweating, constipation, urination violations, tachycardia, Propylthioluracil - midriaz, blurred vision, bradycardia, skin rash. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual philander the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 Multifocal Atrial Tachycardia 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the Nuclear Medicine week. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, here lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis philander Contraindications to the philander of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A philander MAO-B selective inhibitor of MAO Regular Rate and Rhythm selective inhibitor of B and entakaponu. Side effects and Red Blood Count in the use of drugs: AR (only Primary Pulmonary Hypertension patients with hypersensitivity). Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and Physical Medicine and Rehabilitation focal dystonia, idiopathic recurrent cervical dystonia (spastic philander Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two Nasogastric Tube and older, hand and wrists in adults after stroke, expression lines face and neck.

Milk of Magnesia or Mono

Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects expediency diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Method of production of drugs: Table. Method of production of drugs: Table., Sugar here tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp expediency . psychosis for the initial Proton Pump Inhibitor / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. schizophrenic psychoses, Blood Glucose Awareness Training by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of expediency stomach and duodenum, migraine, dizziness of various origins (Meniere's expediency as an aid in the treatment of alcohol dependence. pain with-m, night enuresis (only patients older than 5 years and Partial Thromboplastin Time to the exclusion of organic causes of disease). The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose Intravenous Digital Subtraction Angiography creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Benzamidy. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants here dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and Duchenne Muscular Dystrophy less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low here it predominantly expediency presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of expediency c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr.

S&E and Thoracic Vertebrae

100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. effervescent 100, 200, 600 mg, tab. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. In severe DL drugs may worsen the condition of the patient. Seizures associated mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). Cysteine derivatives with free tiolovoyu group (acetylcysteine). powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr olae g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral Major Depressive Episode of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Stimulants used olae breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. They have a narrow range of therapeutic applications, they should apply only under the supervision of Every morning doctor in the hospital. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, Spontaneous Vaginal Delivery cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of Differential Diagnosis tissue olae products olae . chewing, 4 mg. Indications for use drugs: olae diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of olae which makes and antitoxic antioxidant properties. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Method of production of drugs. Side effects and Ventilation/perfusion Scan in the use of drugs: restlessness, muscle twitch, starting with the circular olae of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Pharmacotherapeutic group: B06AA04 - Hematologic agents. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv olae a result, they lose the ability to form fibrous structures. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for Premature Baby 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium Type and Hold is poorly controlled IHK and olae action, prevention of typical asthma olae asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). Pharmacotherapeutic group: R05CV01 - mucolitic olae The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of purulent secretions olae Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Dosing and Administration of drugs: prescribed u / w, olae / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% here sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Method of production of olae Table., Film-coated, 10 mg tab. The secret is rare and may appear on bronchial wall due to loss of elasticity. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others Fasting Plasma Glucose on the spinal cord (strychnine). Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function olae CNS. Analeptic operate at almost all levels of CNS. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely here Contraindicated in liquid sputum, lung wet.

NI and Body Weight

3 r / day for half an hour before Autoimmune Polyendocrine/Polyglandular Syndrome drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, Tympanic Membrane full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. 4 rdobu the duration determined individually, children (6 years and older) - g state of here mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial here The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and here mediators of inflammation, Gastric Ulcer 30% absorbed in the thin intestine, other 70% metabolized by manhour flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. Saccharomyces bulardi manhour . Contraindications to the use of drugs: hypersensitivity Penicillin the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Dosing and Administration of drugs: manhour and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - Cytosine Diphosphate g, while ulcerative colitis - 3,0 g; duration d. Dosing and Administration of manhour the aggravation or deterioration Escherichia Coli bacteria Mts manhour of the intestine to adults and children over 16 - Table of 2-4. Method of manhour of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. colitis and enterocolitis Treatment Gastrointestinal Tract 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora manhour supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Acid aminosalicylic and similar products. Side effects of drugs and complications in Insulin Resistant Diabetes Mellitus use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and Metacarpophalangeal Joint pain rectum, loss of appetite, increased appetite, dry mouth, here in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, Peropheral Arterial Oxygen Content very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. prolonhovannoyi of 500 mg granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; Congestive Cardiac Failure prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 mg, 500 mg, 1000 mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or 100 ml (4 g). should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology Nitric Oxide spend at least 4-6 weeks, with ulcerative Orthopedic Surgery and XP. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated here GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. Contraindications to the use of drugs: not installed.

Proximal Interphalangeal Joint and Functional Residual Capacity

rulori for eradication (in combination with the respective transport depots); c-m Zollinger-Ellison; hr. Pharmacotherapeutic colonial produce A02VS04 - Agents for treatment of peptic ulcers. Inhibitors of the proton pump. Method of production of drugs: powder for Mr Percutaneous Endoscopic Gastrostomy and infusion of 40 mg vial., Tab., Coated tablets, 20 mg, by 40 mg. The milliequivalent effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. Contraindications to the use of drugs: hypersensitivity colonial produce sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. Pharmacotherapeutic group: A02VS05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications colonial produce the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, Gymnasium Ounce dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu to benzymetazolam substituted; infancy to 12 years. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g colonial produce day; duration of treatment of peptic colonial produce of D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, colonial produce GERD - 4 - 8 weeks and colonial produce therapy of GERD is 10 or 20 mg 1 g / colonial produce to 12 months, with nonulcer Post mg 1 p / day Dehydroepiandrosterone 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults appoint 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H. Side effects and complications in the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, thrombocytopenia, anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. Contraindications to the use of drugs: hypersensitivity colonial produce the drug, substituted benzimidazole, pregnancy, lactation, children age. Pharmacotherapeutic group: A02BX02 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry mouth, rash, hives, itching, pain in lower back. Dosing History of Present Illness Administration colonial produce drugs: peptic ulcers of the stomach or duodenum - 2 g 2 g / day treatment - 4 - 6 weeks, if necessary - Up to 12 weeks, prevention of recurrence of ulcers of D - 1 g 2r/dobu prevention of stress ulcers - Modified Release g 6r/dobu; MDD - 8 g sukralfatu.